At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graftdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment With the Zenith® Fenestrated AAA Endovascular Graft and the Zenith® p-Branch® and the Effects on Organ and Extremity Perfusion
In Brief
A clinical study evaluating Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft for Aortic Aneurysm, Abdominal. Completed, enrolled 28 participants across 2 sites.
Detailed Summary
The Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Single-Center Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic aneurysms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Abdominal
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedJul 2012
Primary CompletionSep 2023
TodayJul 2026
First PostedJul 30, 2012
Enrollment StartJul 1, 2008
Primary CompletionSep 26, 2023
TodayJul 2, 2026
Enrollment to primary: 15.2 yearsPosted 13.9 years ago
Interventions
Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graftdevice
Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.